scispace - formally typeset
S

Sverre E. Kjeldsen

Researcher at University of Oslo

Publications -  771
Citations -  95426

Sverre E. Kjeldsen is an academic researcher from University of Oslo. The author has contributed to research in topics: Blood pressure & Left ventricular hypertrophy. The author has an hindex of 94, co-authored 735 publications receiving 89059 citations. Previous affiliations of Sverre E. Kjeldsen include University of Michigan & Cornell University.

Papers
More filters
Journal ArticleDOI

Seasonal covariation in physical fitness and blood pressure at rest and during exercise in healthy middle-aged men

TL;DR: The seasonal variation in systolic blood pressure at rest and during exercise in apparently healthy middle-aged men may be explained by a parallelseason variation in physical fitness.
Journal ArticleDOI

Cardiovascular Morbidity and Mortality in Hypertensive Patients With Lower Versus Higher Risk A LIFE Substudy

TL;DR: It is hypothesized that losartan was superior to atenolol in reducing cardiovascular events in a lower-risk group (LRG) versus a higher- risk group (HRG) of patients in a Losartan Intervention For Endpoint reduction (LIFE) substudy, independently of blood pressure (BP) reduction.
Journal ArticleDOI

Patients with treatment-resistant hypertension report increased stress and anxiety: A worldwide study

TL;DR: People with rHTN reported consistently greater impact than patients with uHTN, including a poorer perception of their overall health, greater degree of concern over their elevated BP, and a greater impact on their everyday lives.
Journal ArticleDOI

Are fixed-dose combination antihypertensives suitable as first-line therapy?

TL;DR: Earlier use of antihypertensive FDC (including first-line) may help to shrink the current gap between antihyertensive use and BP target control achieved, and suggest that physicians may need to readdress their approach to anti Hypertensive treatment.
Journal ArticleDOI

No Support for Renal Denervation in a Meta-Analysis

TL;DR: The authors computed pooled statistics for 3 so-called controlled studies and 9 observational studies for the blood pressure-lowering effects of renal denervation in treatment-resistant hypertensive patients.